Icahn School of Medicine at Mount Sinai Program

The hematopathology fellowship at Mount Sinai Hospital, Icahn School of Medicine, is a comprehensive 12-month training program accredited by the Accreditation Council for Graduate Medical Education (ACGME). This fellowship is tailored to provide in-depth training in the classification and diagnosis of hematolymphoid disorders, crucial for the effective management of complex patient cases.

The program boasts an extensive hospital network that serves a diverse patient population. Annually, the hematopathology division processes a significant volume of specimens, including over 3,800 surgical hematolymphoid specimens, 3,000 bone marrow biopsies, and 6,000 flow cytometry specimens, allowing fellows to gain extensive practical experience 1.

Curriculum and Clinical Training

Fellows spend approximately 90 percent of their training directly involved in patient management, with the remaining 10 percent dedicated to pursuing research interests. Clinical responsibilities encompass all aspects of diagnostic work-up, including reviewing clinical histories, preparing reports, and participating in sign-out sessions. Educational opportunities include formal presentations at pathology conferences, didactic sessions, and engagement in training residents 1.

The rotation schedule within the program is designed to expose fellows to the Mount Sinai Health System's state-of-the-art clinical laboratories, which have received certifications from the New York State Department of Health and accreditations from the College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA). These experiences ensure that fellows are well-versed in laboratory management, quality assurance, and regulatory issues, further enhancing their educational experience 1.

Research Opportunities

Research within the program focuses on the biology and mechanisms of hematopoietic neoplasms and cancer biology across all age groups. This research spans both basic science and clinical translational studies, contributing to advancements in precision medicine and providing accuracy in diagnosis for clinical trials related to hematologic malignancies. Fellows are encouraged to engage in collaborative research that impacts both national and international healthcare practices 1.

Application Information and Requirements

Starting with the July 2026 appointments, the hematopathology fellowship at Mount Sinai will participate in the NRMP Match. Interested candidates must meet specific application requirements: applicants must be eligible for board certification in anatomic pathology (AP) or anatomic and clinical pathology (AP/CP), and be qualified for New York state medical licensure. Consideration may be given to applicants with clinical pathology (CP)-only training on a case-by-case basis 1.

Applicants must submit a comprehensive application packet, which should include: a personal statement, CAP application form, curriculum vitae (CV), three letters of recommendation, United States Medical Licensing Examination transcript, and documentation of medical training and immigration status. Optional documents can include resident in-service examination scores and copies of published papers 1.

Diversity and Competitiveness

The fellowship program at Mount Sinai emphasizes a commitment to producing leaders in hematopathology and ensures a supportive educational environment that caters to diverse backgrounds. The program is recognized as being competitive, welcoming applicants who are U.S. citizens, legal permanent residents, and international medical graduates (IMGs), provided they meet eligibility criteria 2.

Visa Support

For international candidates, the program offers visa support for qualified applicants. This includes sponsorship for relevant visa types necessary for training, facilitating the participation of international medical graduates who meet the program's application requirements 1.

Unique Aspects of the Program

The hematopathology fellowship at Mount Sinai is distinguished not only by its extensive training and research opportunities but also by its faculty, who are prominent leaders in the field. They bring a wealth of knowledge and experience that enhances fellowships' educational environment and supports their development into proficient hematopathologists, equipped for both academic and private practice 1. Fellows are immersed in collaborative clinical environments, gaining critical insights through participation in multidisciplinary case management and tumor board discussions, further enriching their training experience.